PARP1 and neoplasm: This could be another mechanism on how AKT inhibitor increases anti-tumor efficacy of PARP inhibitor in addition to enhancing HRD, although more studies are needed to elucidate the detailed signaling pathway changes after the use of AKT inhibitor.